Conversely, higher percentages of CD8+ CD127+ lymphocytes, CD8+ LAG3+ lymphocytes, CD8+ PD-1+ lymphocytes and IDO+ MDSCs were found in tumor samples. This evidence concerns the gene CD8A and neoplasm.